Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like Eywa Pharma Gets 483 for Inadequate Investigation, Validation Changes and Cleaning Procedures June 10, 2022 Court Invalidates Five Mallinckrodt Patents September 12, 2017 Scynexis Touts Positive Interim Phase 3 Data for Antifungal Ibrexafungerp April 22, 2022
Eywa Pharma Gets 483 for Inadequate Investigation, Validation Changes and Cleaning Procedures June 10, 2022